The US FDA has scheduled a Pediatric Advisory Committee (PEDAC) meeting for Wednesday, September 14, 2016 to discuss pediatric-focused safety reviews, for certain products that are mandated by the Best Pharmaceuticals for Children Act, the Pediatric Research Equity Act, and the Pediatric Medical Device Safety and Improvement Act.
See the SAC Tracker report